Maven Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-702
| Closed | -$617K | – | 492 |
|
|
2023
Q4 | $617K | Buy |
702
+411
| +141% | +$361K | 0.01% | 132 |
|
|
2023
Q3 | $239K | Buy |
+291
| New | +$239K | ﹤0.01% | 249 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 462 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 458 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 447 |
|
|
2022
Q3 | – | Sell |
-1,238
| Closed | -$732K | – | 545 |
|
|
2022
Q2 | $732K | Buy |
1,238
+812
| +191% | +$480K | 0.02% | 151 |
|
|
2022
Q1 | $298K | Buy |
426
+26
| +7% | +$18.2K | 0.01% | 272 |
|
|
2021
Q4 | $253K | Buy |
+400
| New | +$253K | 0.01% | 294 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 767 |
|
|
2021
Q2 | – | Sell |
-520
| Closed | -$246K | – | 923 |
|
|
2021
Q1 | $246K | Sell |
520
-1,078
| -67% | -$510K | 0.01% | 517 |
|
|
2020
Q4 | $772K | Buy |
1,598
+616
| +63% | +$298K | 0.08% | 266 |
|
|
2020
Q3 | $557K | Buy |
982
+610
| +164% | +$346K | 0.05% | 221 |
|
|
2020
Q2 | $232K | Buy |
+372
| New | +$232K | 0.02% | 206 |
|